CE Webinar Series: IPOST Training
CE Webinar Series: IPOST Training
Tuesday, April 16, 2024 (12:00 PM - 1:00 PM) (CDT)
Description
Title: IPOST: Putting Impactful Conversations Into Action
Objectives:
- Understand the POLST paradigm movement and Iowa’s IPOST
- Understand the power of the IPOST conversation
- Learn how to use the AsK, Teach, Ask model for having difficult conversations
- Identify common pitfalls in difficult conversations
- Identify common pitfalls with the IPOST form
- Learn strategic language for navigating critical conversations
The IPOST form is a dynamic and actionable provider order form that has been in use in Iowa for over a decade. It is part of the national POLST movement which has been pushing to drive critical conversations, through shared decision making, and capture them in a provider order that is both transportable and clearly actionable towards the patients spoken goals and wishes. Understanding how to utilize the form is paramount to helping defragment a health system that is often riddled with challenges in communication between providers.
Dr. Tom Mouser has been a tertiary Hospice and Palliative Care physician through his role as the Chief Medical Officer at EveryStep for the past 12 years. He is dually boarded in Internal Medicine and Hospice and Palliative Care after completing residency at University of Iowa-Des Moines and fellowship training at Stanford University. Dr. Mouser has spent countless hours at the bedside of those with serious illness and chronic disease helping navigate complex medical decisions guided by the patient’s goals of care. He has served on the Iowa state IPOST task force helping promote understanding and better utilization since its inception.
CME Information:
Des Moines University is the accredited provider and has approved this educational offering for AMA PRA Category 1 Credit™, American Osteopathic Association credit, nursing contact hours, and continuing education contact hours. The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. No ineligible company provided financial support for this continuing education activity. If you have questions regarding continuing education credit, please email cme@dmu.edu.
20